Page 29 - Siam Bioscience News Today

Peer-reviewed / Review, Survey and Opinion piece To ensure an effective global immunisation strategy against COVID-19, vaccines need to be produced at scale, priced affordably, and allocated globally so that they are available where needed, and successfully rolled out. Review of evidence includes a comparison of 26 leading vaccines on their potential contribution to achieving global vaccine immunity, and a new survey of COVID-19 vaccine confidence in 32 countries. Having new COVID-19 vaccines ...

February 11, 2021 The Nation/Asia News Network Thailand will start conducting Phase 1 clinical tests on a locally produced inactivated Covid-19 vaccine from March 1, Public Health Minister Anutin Charnvirakul told the press on Wednesday (Feb 10). He also said that once the tests are complete, the Government Pharmaceutical Organisation (GPO) will produce 25 - 30 million doses in its Saraburi plant, The minister went on to say that the government has already purchased 61 million doses as part of ...

Thai Beverage is preparing to take its brewery business public on the Singapore Exchange in an IPO that could raise over US$2 billion. The firm behind Chang Beer is one of Thailand’s largest conglomerates and the IPO represents a stark contrast as the country’s economy struggles with the impacts of the pandemic and rising wealth inequality. Editorial Drinks conglomerate Thai Beverage has announced that it will list its brewery business on the Singapore Exchange, in what would be the biggest...

PM defends vaccine rollout in podcast 6 Contingency plans to ensure doses secure published : 8 Feb 2021 at 04:30 6 Taxis and private vehicles are seen along Prannok-Kanchanaphisek Road as people converge near the Fai Chai intersection to receive food handouts from disciples of Wat Tha Chang and Wat Rakhang Khositaram. The charity was held to assist people affected by Covid-19 pandemic. Apichart Jinakul Thailand has contingency plans to sec...

BANGKOK (Bloomberg):Thailand will begin clinical trials of a locally developed Covid-19 vaccine in March, making it the nation’s first inoculation programme to enter human trials.

Thailand to Begin Human Trials for Covid-19 Vaccine in March Bloomberg 2/10/2021 Randy Thanthong-Knight © Bloomberg Anutin Charnvirakul, Thailands deputy prime minister and health minister, at his office in Bangkok, Thailand, on Monday, Feb. 8, 2021. Thailand will rely on Covid-19 vaccines from Chinas Sinovac Biotech Ltd. to kick off an inoculation drive that aims to cover about two-thirds of the nations eligible population by the end of this year, potentially paving the wa...

The Thai government is using the controversial lese majeste law to target critics of the monarchy after they demanded clarity about the role of a company owned by the king in the country’s COVID-19 vaccine rollout. The situation is not likely to help save the palace’s reputation or silence its critics. In Thailand, the debate over the timely availability and distribution of a COVID-19 vaccine has become politicized as the country’s monarchy faces accusations of using a deal with AstraZene...

It is reported that lese majeste case No. 58 of the current round of repression has been lodged - we seem to have missed cases 56 and 57 - with a 37 year-old man being charged "with the royal insult, or lese majeste, for allegedly mocking the monarchy at a shopping mall in December...". A…

South Africa said Sunday it would suspend the start of its Covid-19 vaccinations with the AstraZeneca jab -- which forms a major plank of Thailand's vaccination strategy and is to be produced by Siam BioScience in Bangkok -- after a study showed the drug failed to prevent mild and moderate cases of the virus variant that has appeared in Africa's hardest-hit nation.

HEALTH-CORONAVIRUS/THAILAND (UPDATE 1, PIX):UPDATE 1-Thai court overturns takedown order over criticism of vaccine strategy